Vanderbilt, Verily partner on NIH-backed healthcare data platform

Advertisement

A coalition led by Alphabet life sciences arm Verily that includes Nashville, Tenn.-based Vanderbilt University Medical Center has secured a $9.2 million National Institutes of Health award extension to advance a biology data analysis tool.

The FAIRplex platform allows researchers to apply AI and machine learning to find, access and analyze data from the Accelerating Medicines Partnership, a public-private collaboration featuring NIH and the FDA, to more deeply understand the biological systems affecting health and disease. The platform comprises clinical, molecular, phenotypic, and patient-reported outcomes data.

The group is shifting its focus from “foundational development to operational readiness and deeper integration,” per a Dec. 18 news release.

Other coalition members include Cambridge, Mass.-based Broad Institute of MIT and Harvard, Chicago-based Northwestern University Feinberg School of Medicine, and technology companies DataTecnica, Sage Bionetworks and Technome.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement